SWOT Analysis for Suven Life Sciences Ltd. - Threats

Add SWOT widget to your site/app

Companies with no Debt

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Consistent Highest Return Stocks over Five Years

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Volume Shockers

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

Promoter holding decreased by more than -2% QoQ

Negative profit growth, promoters decreasing shareholding QoQ

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Degrowth in Revenue and Profit

Decline in Net Profit (QoQ)

Declining profits every quarter for the past 2 quarters

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

RSI indicating price weakness

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

Red Flags: Weakening Technicals and Share Price Decline

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks